Know Cancer

forgot password

Evaluating Patient Information Prescriptions in Different Service Environments

Phase 2
Open (Enrolling)
Breast Neoplasms, Premature Birth

Thank you

Trial Information

Evaluating Patient Information Prescriptions in Different Service Environments

The goal of this research is to evaluate IRx, to provide enough data so care organizations
can decide whether to implement this in their own environment.

To that end, our specific aims are:

1. To evaluate the impact of IRx on patients. We are performing a randomized clinical
trial, comparing IRx with standard provision of information. The primary outcome is
patient satisfaction.

2. To evaluate the impact of IRx on providers. As part of the trial, provider perceptions
and behavior will be assessed.

3. To evaluate the impact of IRx on the health-care system. As part of the trial, costs
entailed and resources utilized will be assessed.

4. To evaluate how IRx generalizes across service environments. The trial will be
performed in two environments: adult breast cancer and neonatal intensive care.

At the heart of this proposal are the randomized clinical trials. In each, patients in both
intervention and control groups will receive standard clinical care in their clinic visits.
Patients randomized to the intervention group will receive information services from a
specially trained librarian; patients in the control groups will receive routine, current
information provision. For Aim 1, immediately after their clinic visits and four weeks
later, all participants will report their satisfaction on a survey that include measures of
patient-provider communication. For Aim 2, participating providers are surveyed for their
perceptions of information needs being met and about patient-provider interaction. For Aim
3, costs of care and costs of providing the IRx environment will be tabulated.

Inclusion Criteria:

- Breast Cancer: any new patient seen in Johns Hopkins medical oncology for Breast

- Neonatal Intensive care:Biological mothers (or consenting guardians) of premature
infants born and admitted or transferred in to Johns Hopkins Hospital or Bayview
Medical Center neonatal intensive care units.

Exclusion Criteria:

- Breast Cancer: None

- Neonatal Intensive Care: Parents with infants whose SNAP mortality >= 80%(J Pediatr.
2001 Jan;138(1):92-100)

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Outcome Measure:

Patient Satisfaction

Outcome Time Frame:

4 years

Safety Issue:


Principal Investigator

Nancy K Oliver, MLS

Investigator Role:

Principal Investigator

Investigator Affiliation:

Johns Hopkins School of Medicine


United States: Institutional Review Board

Study ID:

JHU 04-09-03-01



Start Date:

September 2004

Completion Date:

September 2009

Related Keywords:

  • Breast Neoplasms
  • Premature Birth
  • Information Services
  • Randomized Controlled Trials
  • Medical Records Systems, Computerized
  • Internet
  • Librarians
  • Breast Neoplasms
  • Patient Satisfaction
  • Health Personnel
  • Costs and Cost Analysis
  • Premature Birth
  • Breast Neoplasms
  • Neoplasms
  • Premature Birth



Johns Hopkins School of Medicine Baltimore, Maryland  21205